LACUTAMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 13:34:32 GMT 2023` Edited by `admin` on `Sat Dec 16 13:34:32 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	N8O7MY0VNS
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

LACUTAMAB

Official Name

English

IPH4102

Code

English

IMMUNOGLOBULIN G1(240-ASPARTIC ACID, 333-GLUTAMIC ACID), ANTI-(HUMAN KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR3DL2) (HUMAN-MUS MUSCULUS MONOCLONAL IPH4102 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL IPH4102 .KAPPA.-CHAIN, DIMER

Systematic Name

English

IPH-4102

Code

English

lacutamab [INN]

Common Name

English

ANTI-KIR3DL2 MONOCLONAL ANTIBODY IPH4102

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C20401

Created by admin on Sat Dec 16 13:34:32 GMT 2023 , Edited by admin on Sat Dec 16 13:34:32 GMT 2023

FDA ORPHAN DRUG

574717

Created by admin on Sat Dec 16 13:34:32 GMT 2023 , Edited by admin on Sat Dec 16 13:34:32 GMT 2023

NCI_THESAURUS

C129822

Created by admin on Sat Dec 16 13:34:32 GMT 2023 , Edited by admin on Sat Dec 16 13:34:32 GMT 2023

EU-Orphan Drug

EU/3/14/1322

Created by admin on Sat Dec 16 13:34:32 GMT 2023 , Edited by admin on Sat Dec 16 13:34:32 GMT 2023

Code System Code Type Description

INN

10924

Created by admin on Sat Dec 16 13:34:32 GMT 2023 , Edited by admin on Sat Dec 16 13:34:32 GMT 2023

PRIMARY

NCI_THESAURUS

C124999

Created by admin on Sat Dec 16 13:34:32 GMT 2023 , Edited by admin on Sat Dec 16 13:34:32 GMT 2023

PRIMARY

FDA UNII

N8O7MY0VNS

Created by admin on Sat Dec 16 13:34:32 GMT 2023 , Edited by admin on Sat Dec 16 13:34:32 GMT 2023

PRIMARY

CAS

2187368-16-5

Created by admin on Sat Dec 16 13:34:32 GMT 2023 , Edited by admin on Sat Dec 16 13:34:32 GMT 2023

PRIMARY

DRUG BANK

DB15322

Created by admin on Sat Dec 16 13:34:32 GMT 2023 , Edited by admin on Sat Dec 16 13:34:32 GMT 2023

PRIMARY

From	To
1_22	1_96
1_145	1_201
1_221	3_214
1_227	2_227
1_230	2_230
1_262	1_322
1_368	1_426
2_22	2_96
2_145	2_201
2_221	4_214
2_262	2_322
2_368	2_426
3_23	3_88
3_134	3_194
4_23	4_88
4_134	4_194

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_298
N	2_298

Related Record Type Details


					N8O7MY0VNS

LACUTAMAB

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL